本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Atara Biotherapeutics

9.60
+0.16001.69%
成交量:1.19萬
成交額:11.37萬
市值:9,636.19萬
市盈率:-8.07
高:9.87
開:9.29
低:9.07
收:9.44
52周最高:19.15
52周最低:3.92
股本:1,003.77萬
流通股本:462.30萬
量比:2.93
換手率:0.26%
股息:- -
股息率:- -
每股收益(TTM):-1.1889
每股收益(LYR):2.57
淨資產收益率:-2014.86%
總資產收益率:-24.14%
市淨率:-2.60
市盈率(LYR):3.74

資料載入中...

2021/08/09

重要事件披露

8-K - Current report
2021/08/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/09

重要事件披露

8-K - Current report
2021/05/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/04

重要事件披露

8-K - Current report
2021/03/01

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/01

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/01

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/11

重要事件披露

8-K - Current report
2021/01/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/04

重要事件披露

8-K - Current report
2020/12/09

重要事件披露

8-K - Current report
2020/12/07

重要事件披露

8-K - Current report